Search
Now showing items 1-10 of 17
The association between ischemia modified albumin and placental histopathology in uncomplicated term deliveries
(2015)
Ischemia modified albumin (IMA) is a marker of ischemia elevated in different clinical conditions and its
use for hypoxia in perinatology is of current interest. We aimed to investigate the association between
maternal ...
Cyc-C is superior to creatinine in the early diagnosis of contrast-induced nephropathy
(2013-08)
[No Abstract Available]
Collagen cross-links as a marker for subclinical atherosclerosis in postmenopausal women
(2014)
[No Abstract Available]
The role of bilirubin and its protective function against coronary heart disease
(2014)
BACKGROUND:Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality both in industrialized and developing countries. Atherosclerosis is a chronic inflammatory disease of the arterial wall, ...
Ischemia modified albumin in perinatology
(2016-12-19)
Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and
increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early
marker for acute coronary ...
Maternal and fetal blood levels of S100 and ischaemia modified albumin in term intrauterine growth restricted fetuses with abnormal umbilical artery doppler values
(2015-05)
The purpose of this study was to investigate whether levels of fetal hypoxia markers, S100 and ischaemia modified albumin (IMA) change in cases of intrauterine growth restriction (IUGR). This case-control study included ...
The evaluation of IMA as a cardiac ischemia marker in the cases of hypohemoglobinemia and hypoxemia due to blood loss
(2014)
Objective: Although the mechanism is still not so clear, ischemia modified albumin is produced as a result of the occurrence of changes in metal binding regions on the albumin with
the production of reactive oxygen species. ...
Is direct method of low density lipoprotein cholesterol measurement appropriate for targeting lipid lowering therapy?
(2009-01-08)
[No Abstract Available]
Is serum S100 protein associated with the angiographic severity of coronary artery disease in acute coronary syndromes?
(2013-10-29)
[No Abstract Available]
Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes
(2018-08-08)
Metformin is used to reduce hyperglycemia that induces energetic stress and leads to reduction in
gluconeogenesis. Also, metformin inhibits complex I in oxidative phosphorylation, thereby decreasing
cellular ATP levels. ...